Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients

P279 Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients

International Journal of Antimicrobial Agents ◽

10.1016/s0924-8579(13)70520-x ◽

2013 ◽

Vol 42 ◽

pp. S130

Author(s):

N. Furusyo ◽

M. Murata ◽

E. Ogawa ◽

H. Nomura ◽

J. Hayashi

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Hepatocellular Carcinoma Recurrence ◽

766 A PANEL OF GENE EXPRESSION BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) IN CHRONIC HEPATITIS C PATIENTS (CH-C) TREATED WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN

Journal of Hepatology ◽

10.1016/s0168-8278(08)60768-0 ◽

2008 ◽

Vol 48 ◽

pp. S286

Author(s):

Z.M. Younossi ◽

A. Baranova ◽

M. Stepanova ◽

A. Afendy ◽

A. Wheeler ◽

...

Keyword(s):

Gene Expression ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Sustained Virologic Response ◽

Pegylated Interferon ◽

Virologic Response ◽

Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment

Journal of Clinical Virology ◽

10.1016/j.jcv.2006.08.014 ◽

2006 ◽

Vol 37 (4) ◽

pp. 329-331 ◽

Cited By ~ 2

Author(s):

Ioannis S. Elefsiniotis ◽

Aikaterini Petrocheilou ◽

Nikolaos Scarmeas ◽

Ioannis Ketikoglou ◽

Konstantinos D. Pantazis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

P.247 Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)

Journal of Clinical Virology ◽

10.1016/s1386-6532(06)80427-0 ◽

2006 ◽

Vol 36 ◽

pp. S138

Author(s):

G. Esmat ◽

H. ElMakhzangy ◽

S. Males ◽

R.R. Gad ◽

C. Rekacewicz ◽

...

Keyword(s):

Chronic Hepatitis ◽

Treatment Outcome ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Genotype 4 ◽

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

Journal of Hepatology ◽

10.1016/j.jhep.2012.10.017 ◽

2013 ◽

Vol 58 (3) ◽

pp. 495-501 ◽

Cited By ~ 89

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Eiji Kajiwara ◽

Kazuhiro Takahashi ◽

Hideyuki Nomura ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Multicenter Study ◽

Pegylated Interferon ◽

Prospective Multicenter Study ◽

Interferon Alpha 2B

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients

Gastroenterology Research and Practice ◽

10.1155/2008/637517 ◽

2008 ◽

Vol 2008 ◽

pp. 1-3 ◽

Cited By ~ 1

Author(s):

Konstantinos D. Pantazis ◽

Ioannis S. Elefsiniotis ◽

Dimitrios Papaioannou ◽

Hero Brokalaki ◽

Gerasimos Bonatsos ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Large Intestine ◽

Interferon Alpha ◽

Pegylated Interferon ◽

An early prognosis for the treatment of Chronic Hepatitis C patients with Pegylated Interferon-.ALPHA.2b plus Ribavirin-Monitoring analysis by the serum HCV core antigen values-

Kanzo ◽

10.2957/kanzo.47.355 ◽

2006 ◽

Vol 47 (7) ◽

pp. 355-356

Author(s):

Tatsuya Fujino ◽

Kazuto Goto ◽

Eiichiro Arimura ◽

Yumiko Sakiyama ◽

Ryosuke Takemoto ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Core Antigen ◽

Interferon Alpha 2B ◽

Hcv Core Antigen ◽

Factors affecting efficacy of pegylated interferon alpha-2a in chronic hepatitis C patients with serotype 2

Kanzo ◽

10.2957/kanzo.52.236 ◽

2011 ◽

Vol 52 (4) ◽

pp. 236-243 ◽

Cited By ~ 2

Author(s):

Keiko Irishio ◽

Yasuharu Imai ◽

Eiji Mita ◽

Takashi Toyama ◽

Noriyoshi Kuzushita ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Factors Affecting ◽

Zinc Supplementation Prevents the Increase of Transaminase in Chronic Hepatitis C Patients during Combination Therapy with Pegylated Interferon .ALPHA.-2b and Ribavirin

Journal of Nutritional Science and Vitaminology ◽

10.3177/jnsv.53.213 ◽

2007 ◽

Vol 53 (3) ◽

pp. 213-218 ◽

Cited By ~ 28

Author(s):

Yasuko MURAKAMI ◽

Tomoko KOYABU ◽

Aiko KAWASHIMA ◽

Naoko KAKIBUCHI ◽

Takayo KAWAKAMI ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Zinc Supplementation ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

Value in Health ◽

10.1016/j.jval.2011.08.239 ◽

2011 ◽

Vol 14 (7) ◽

pp. A274-A275

Author(s):

T. Macioch ◽

J. Paweska ◽

M. Niewada ◽

H. Berak ◽

M. Szkultecka-Debek ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Effectiveness Analysis ◽